![Bhaskar Chaudhuri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bhaskar Chaudhuri
Fondateur chez
ARCUTIS BIOTHERAPEUTICS, INC.
Fortune : 25 M $ au 30/09/2026
Profil
Dr. Bhaskar Chaudhuri is an Independent Director at Tarsus Pharmaceuticals, Inc., a Director Emeritus at Arcutis Biotherapeutics, Inc. and a Senior Advisor at Frazier Management LLC.
He is on the Board of Directors at Tarsus Pharmaceuticals, Inc. Dr. Chaudhuri was previously employed as an Independent Director by Teligent, Inc., an Independent Non-Executive Director by Corium Inc., a President by Valeant Pharmaceuticals International Corp., a President, Chief Executive Officer & Director by Dow Pharmaceutical Sciences, Inc., an Executive Vice President-Scientific Affairs by Bertek Pharmaceuticals, Inc., a General Manager-Dermatology Division by Mylan Laboratories, Inc., and a Vice President-Research & Development by Penederm, Inc. He also served on the board at Sudo Biosciences, Inc., Vyome Therapeutics, Inc., Thesan Pharmaceuticals, Inc. and Silvergate Pharmaceuticals, Inc. He received his undergraduate degree from Jadavpur University, a graduate degree from Jadavpur University and a doctorate degree from Louisiana State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2025 | 917 807 ( 0,73 % ) | 24 M $ | 30/09/2026 | |
| 25/06/2026 | 11 654 ( 0,02 % ) | 916 121 $ | 30/09/2026 |
Postes actifs de Bhaskar Chaudhuri
| Sociétés | Poste | Début |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Fondateur | 01/06/2016 |
| TARSUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/12/2019 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Consultant / Advisor | 01/01/2011 |
Anciens postes connus de Bhaskar Chaudhuri
| Sociétés | Poste | Fin |
|---|---|---|
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Directeur/Membre du Conseil | 10/01/2024 |
| TELIGENT | Directeur/Membre du Conseil | 21/07/2021 |
Silvergate Pharmaceuticals, Inc.
 Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | 12/06/2019 |
| CORIUM INTERNATIONAL INC | Directeur/Membre du Conseil | 27/11/2018 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | President | 01/09/2010 |
Formation de Bhaskar Chaudhuri
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
VJGJ, Inc.
 VJGJ, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Mylan Laboratories, Inc.
 Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Penederm, Inc.
 Penederm, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets a line of skin care drugs and products | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Mylan Bertek Pharmaceuticals, Inc.
 Mylan Bertek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Silvergate Pharmaceuticals, Inc.
Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces novel therapeutics for skin disorders | Health Technology |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dow Pharmaceutical Sciences, Inc.
 Dow Pharmaceutical Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes topical drug products | Health Technology |
Jadavpur University
 Jadavpur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Vyome Therapeutics, Inc.
 Vyome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company that develops medicines to treat immuno-inflammatory diseases | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Tarsus Pharmaceuticals, Inc.
 Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
